Hepatitis B og C
-
Hepatitis B (2025)Version 9.
Udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin og Dansk Selskab for Gastroenterologi og Hepatologi.
-
Screening før behandling med biologiske og målrettede syntetiske lægemidler (2023)
-
Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
-
REACH-B Score for Hepatocellular Carcinoma (MDCalc)
https://www.mdcalc.com/calc/10031/reach-b-score-hepatocellular-carcinoma-hcc
-
Hepatitis B Core‐Related Antigen Level Predicts Disease Progression in the Gray Zone Hepatitis B PatientsJournal of Medical VirologyTilføjet 10. april 2026
-
Impact of Hepatitis B Exposure and/or HIV Co‐Infection on Clinical Outcomes in Chronic Hepatitis C Patients in Oman: An Ambidirectional Cohort StudyJournal of Medical VirologyTilføjet 10. april 2026
-
Burden of human immunodeficiency virus and hepatitis B and C viruses in incoming Venezuelan migrants at the Colombian border: a laboratory-based cross-sectional study, 2021-2023Clinical Microbiology and InfectionTilføjet 8. april 2026
-
Multimorbidity patterns and their associations with healthcare services utilisation in inpatients with chronic hepatitis B infection from 2011 to 2023: a retrospective observational studyBMJ OpenTilføjet 7. april 2026
-
Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐AnalysisJournal of Medical VirologyTilføjet 20. marts 2026
-
Expression of Concern: Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, PakistanPLoS One Infectious DiseasesTilføjet 20. marts 2026
-
Serum sIL-2R Predicts Significant Histological Disease in Indeterminate Phase Chronic Hepatitis BInternational Journal of Infectious DiseasesTilføjet 19. marts 2026
-
Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral TherapyJournal of Medical VirologyTilføjet 20. marts 2026
-
The Cost-Effectiveness of Universal Hepatitis B Screening in VietnamInternational Journal of Infectious DiseasesTilføjet 19. marts 2026
-
A Genetic Variant of TLR6 Predicts HBsAg Decline After Pegylated Interferon‐Alpha Treatment in HBeAg‐Positive Chronic Hepatitis BJournal of Medical VirologyTilføjet 15. marts 2026
-
Hepatitis B virus infection and its determinants among pregnant women in Ethiopia: protocol for umbrella review of systematic review and meta-analysis 2025BMJ OpenTilføjet 4. marts 2026
-
Hepatitis B Vaccination Coverage and Vaccine‐Associated Immunity Among US‐Born Children and Adolescents: NHANES 2017–2020Journal of Medical VirologyTilføjet 23. februar 2026
-
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide StudyJournal of Medical VirologyTilføjet 8. februar 2026
-
Construction of a depression risk prediction model for hepatitis B patients based on machine learning strategyPLoS One Infectious DiseasesTilføjet 5. februar 2026
-
Metabolic multimorbidity and liver fibrosis among people with hepatitis B in SenegalInternational Journal of Infectious DiseasesTilføjet 2. februar 2026
-
Hepatitis B virus (HBV) DNA is present as both cccDNA and integrated forms in kidney tissues of HBV surface antigen-negative patients with renal cell carcinomaInternational Journal of Infectious DiseasesTilføjet 28. januar 2026
-
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo modelsAntimicrobial Agents And ChemotherapyTilføjet 27. januar 2026
-
Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort studyPLoS One Infectious DiseasesTilføjet 24. januar 2026
-
PEP-Hep: A cluster randomised controlled trial of a prison education programme to improve hepatitis B and C testing uptake and treatment initiation in Ghana - A study protocolBMJ OpenTilføjet 23. januar 2026
-
HepB-Boost: Implementation of free of charge healthcare worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya.International Journal of Infectious DiseasesTilføjet 23. januar 2026